Pacira BioSciences, Inc. (PCRX) › Operating Cash FlowPacira BioSciences, Inc. (PCRX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: $17.79M2018: $48.87M2019: $70.52M2020: $77.03M2021: $125.72M2022: $145.27M2023: $154.65M2024: $189.39M2025: $151.99M$151.99M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$151.99M-19.7%2024$189.39M+22.5%2023$154.65M+6.5%2022$145.27M+15.6%2021$125.72M+63.2%2020$77.03M+9.2%2019$70.52M+44.3%2018$48.87M+174.8%2017$17.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share